Loading…
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
AAV vectors that efficiently transduce the mouse brain after intravenous injection are generated with a CRE-dependent selection system. Recombinant adeno-associated viruses (rAAVs) are commonly used vehicles for in vivo gene transfer 1 , 2 , 3 , 4 , 5 , 6 . However, the tropism repertoire of natural...
Saved in:
Published in: | Nature biotechnology 2016-02, Vol.34 (2), p.204-209 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | AAV vectors that efficiently transduce the mouse brain after intravenous injection are generated with a CRE-dependent selection system.
Recombinant adeno-associated viruses (rAAVs) are commonly used vehicles for
in vivo
gene transfer
1
,
2
,
3
,
4
,
5
,
6
. However, the tropism repertoire of naturally occurring AAVs is limited, prompting a search for novel AAV capsids with desired characteristics
7
,
8
,
9
,
10
,
11
,
12
,
13
. Here we describe a capsid selection method, called Cre recombination–based AAV targeted evolution (CREATE), that enables the development of AAV capsids that more efficiently transduce defined Cre-expressing cell populations
in vivo
. We use CREATE to generate AAV variants that efficiently and widely transduce the adult mouse central nervous system (CNS) after intravenous injection. One variant, AAV-PHP.B, transfers genes throughout the CNS with an efficiency that is at least 40-fold greater than that of the current standard, AAV9 (refs.
14
,
15
,
16
,
17
), and transduces the majority of astrocytes and neurons across multiple CNS regions.
In vitro
, it transduces human neurons and astrocytes more efficiently than does AAV9, demonstrating the potential of CREATE to produce customized AAV vectors for biomedical applications. |
---|---|
ISSN: | 1087-0156 1546-1696 |
DOI: | 10.1038/nbt.3440 |